BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6278660)

  • 1. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental relation between leukocytosis and other factors of Bordetella pertussis].
    Ruiz Puente J; Rivera Rivera D; González Pacheco M
    Salud Publica Mex; 1981; 23(6):613-20. PubMed ID: 6278659
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphological alterations of the adrenal gland following administration of histamine-sensitizing-factor of Bordetella pertussis.
    Kuwajima Y
    Osaka City Med J; 1980; 26(1):61-6. PubMed ID: 6267538
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between growth rate and loss of histamine-sensitizing factor during antigenic modulation in Bordetella pertussis.
    Idigbe EO
    Microbios; 1987; 49(199):79-89. PubMed ID: 2883559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
    Smirnov VD; Chuprinina RP; Siundiukova RA; Maksiutov RV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine-sensitizing factor of Alcaligenes faecalis.
    Simmons DG; Rose LP; McCorkle FM; Luginbuhl GH
    Avian Dis; 1983; 27(1):171-7. PubMed ID: 6682654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 10. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium.
    Idigbe EO; Parton R; Wardlaw AC
    J Med Microbiol; 1981 Nov; 14(4):409-18. PubMed ID: 6273564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of lipopolysaccharide from acellular Bordetella pertussis vaccine by detergent treatment.
    Stinson RS; Lemmon RD; Baggett DW; Huff TL; Malone JA; Sloan GL; Winters AL
    J Biol Stand; 1986 Oct; 14(4):261-71. PubMed ID: 2881930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purification and characterization of an acellular pertussis vaccine.
    Chazono M; Yoshida I; Konobe T; Fukai K
    J Biol Stand; 1988 Apr; 16(2):83-9. PubMed ID: 2897370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.
    Ben-Nun A; Mendel I; Kerlero de Rosbo N
    Proc Assoc Am Physicians; 1997 Mar; 109(2):120-5. PubMed ID: 9069580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
    Burnette WN
    Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 19. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    Ackers JP; Dolby JM
    J Gen Microbiol; 1972 Apr; 70(2):371-82. PubMed ID: 4338965
    [No Abstract]   [Full Text] [Related]  

  • 20. Interconnexion between the protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    JOO I; PUSZTAI Z
    Nature; 1960 Oct; 188():331-2. PubMed ID: 13790658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.